Evidence map›Paper›PMID 39970152›Full record

ArticlePloS one2025

Genetic adaptation to amoxicillin in Escherichia coli: The limited role of dinB and katE.

Lisa Teichmann, Marcus Wenne, Sam Luitwieler, Gaurav Dugar, Johan Bengtsson-Palme, Benno Ter Kuile

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Effects of Black Soldier Fly (Antioxidants (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lisa TeichmannSwammerdam Institute of Life Sciences, Molecular Biology and Microbial Food Safety, University of Amsterdam, Amsterdam, The Netherlands.
Marcus WenneDepartment of Life Sciences, Division of Systems and Synthetic Biology, SciLifeLab, Chalmers University of Technology, Gothenburg, Sweden.
Sam LuitwielerSwammerdam Institute of Life Sciences, Molecular Biology and Microbial Food Safety, University of Amsterdam, Amsterdam, The Netherlands.
Gaurav DugarSwammerdam Institute of Life Sciences, Molecular Biology and Microbial Food Safety, University of Amsterdam, Amsterdam, The Netherlands.
Johan Bengtsson-PalmeDepartment of Life Sciences, Division of Systems and Synthetic Biology, SciLifeLab, Chalmers University of Technology, Gothenburg, Sweden.
Benno Ter KuileSwammerdam Institute of Life Sciences, Molecular Biology and Microbial Food Safety, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-8523-8135

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteria can quickly adapt to sub-lethal concentrations of antibiotics. Several stress and DNA repair genes contribute to this adaptation process. However, the pathways leading to adaptation by acquisition of de novo mutations remain poorly understood. This study explored the roles of DNA polymerase IV (dinB) and catalase HP2 (katE) in E. coli's adaptation to amoxicillin. These genes are thought to play essential roles in beta-lactam resistance-dinB in increasing mutation rates and katE in managing oxidative stress. By comparing the adaptation rates, transcriptomic profiles, and genetic changes of wild-type and knockout strains, we aimed to clarify the contributions of these genes to beta-lactam resistance. While all strains exhibited similar adaptation rates and mutations in the frdD gene and ampC operon, several unique mutations were acquired in the ΔkatE and ΔdinB strains. Overall, this study distinguishes the contributions of general stress-related genes on the one hand, and dinB, and katE on the other hand, in development of beta-lactam resistance.

Indexed as

Adaptation, PhysiologicalAmoxicillinAnti-Bacterial AgentsCatalaseEscherichia coliEscherichia coli Proteinsbeta-Lactam ResistanceGene Expression Regulation, BacterialMutationAmoxicillinAnti-Bacterial AgentsCatalaseEscherichia coli Proteins

Identifiers

PMID39970152
PMCPMC11838884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.